Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-13 5:00 pm Sale | 13G | BOLT BIOTHERAPEUTICS, INC BOLT | Vivo Capital VIII LLC | 2,073,005 5.5% | -200,000 (-8.80%) | View |
| 2023-02-13 5:57 pm Purchase | 13G | TERNS PHARMACEUTICALS INC TERN | Vivo Capital VIII LLC | 4,340,212 9% | 2,022,432 (+87.26%) | View |
| 2023-02-13 5:56 pm Sale | 13G | HARMONY BIOSCIENCES HLDGS INC HRMY | Vivo Capital VIII LLC | 2,571,024 4.3% | -1,729,237 (-40.21%) | View |
| 2022-02-11 5:24 pm Unchanged | 13G | HARMONY BIOSCIENCES HLDGS INC HRMY | Vivo Capital VIII LLC | 4,300,261 7.4% | 0 (Unchanged) | View |
| 2022-02-11 5:22 pm Sale | 13G | CRINETICS PHARMACEUTICALS INC CRNX | Vivo Capital VIII LLC | 0 0% | -1,819,600 (Position Closed) | View |
| 2022-02-11 5:21 pm Sale | 13G | AMYRIS INC AMRS | Vivo Capital VIII LLC | 7,734,621 2.5% | -3,110,475 (-28.68%) | View |
| 2021-05-06 4:30 pm Purchase | 13G | IMPEL PHARMACEUTICALS INC IMPL | Vivo Capital VIII LLC | 2,884,789 14.9% | 2,884,789 (New Position) | View |
| 2021-02-18 4:53 pm Purchase | 13G | TERNS PHARMACEUTICALS INC TERN | Vivo Capital VIII LLC | 2,317,780 9.7% | 2,317,780 (New Position) | View |
| 2021-02-18 4:50 pm Purchase | 13G | BOLT BIOTHERAPEUTICS, INC BOLT | Vivo Capital VIII LLC | 2,273,005 6.6% | 2,273,005 (New Position) | View |
| 2021-02-12 4:30 pm Sale | 13G | PASSAGE BIO INC PASG | Vivo Capital VIII LLC | 1,487,038 11% | -756,459 (-33.72%) | View |
| 2021-02-12 4:30 pm Sale | 13G | AMYRIS INC AMRS | Vivo Capital VIII LLC | 10,845,096 4.5% | -37,560 (-0.35%) | View |
| 2021-02-12 4:30 pm Sale | 13G | CRINETICS PHARMACEUTICALS INC CRNX | Vivo Capital VIII LLC | 1,819,600 5.5% | -425,304 (-18.95%) | View |
| 2021-02-12 4:30 pm Sale | 13G | KADMON HLDGS LLC COM KDMN | Vivo Capital VIII LLC | 4,283,014 2.5% | -6,010,757 (-58.39%) | View |
| 2020-10-28 4:30 pm Purchase | 13G | ALIGOS THERAPEUTICS INC ALGS | Vivo Capital VIII LLC | 3,547,030 10.5% | 3,547,030 (New Position) | View |
| 2020-08-31 7:01 pm Purchase | 13G | HARMONY BIOSCIENCES HLDGS INC HRMY | Vivo Capital VIII LLC | 4,300,261 6.7% | 4,300,261 (New Position) | View |
| 2020-06-11 5:09 pm Sale | 13G | MENLO THERAPEUTICS INC MNLO | Vivo Capital VIII LLC | 3,643,824 2.2% | -367,412 (-9.16%) | View |
| 2020-06-11 5:06 pm Sale | 13G | CRINETICS PHARMACEUTICALS INC CRNX | Vivo Capital VIII LLC | 2,244,904 6.8% | -853,416 (-27.54%) | View |
| 2020-03-06 4:30 pm Purchase | 13G | PASSAGE BIO INC PASG | Vivo Capital VIII LLC | 2,243,497 4.9% | 2,243,497 (New Position) | View |
| 2020-02-13 5:53 pm Purchase | 13G | AMYRIS INC AMRS | Vivo Capital VIII LLC | 10,882,656 9.9% | 10,882,656 (New Position) | View |
| 2020-02-13 5:10 pm Sale | 13G | AGILE THERAPEUTICS INC AGRX | Vivo Capital VIII LLC | 189,247 0.3% | -1,324,728 (-87.50%) | View |